Form 8.3 - Allergan plc

LONDON--()-- 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)

Millennium International Management LP

Company dealt in

Allergan plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

IE00BY9D5467

Date of dealing

27th April 2020

2. INTERESTS AND SHORT POSITIONS

a) Interests and short positions (following dealing) in the class ofrelevant security dealt in(Note 3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

4,331,570

(1.316%)

2,572

(0.001%)

(2) Derivatives (other than options)

-

-

(3) Options and agreements to purchase/sell

-

-

Total

4,331,570

(1.316%)

2,572

(0.001%)

 

b) Interests and short positionsin relevant securitiesof the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit (Note 5)

(USD)

Sale

20,037

188.24

Purchase

100

187.62

Purchase

200

187.69

Purchase

200

187.67

Purchase

200

187.70

Purchase

100

187.74

Purchase

100

187.72

Purchase

100

187.65

Purchase

400

187.68

Purchase

100

187.66

Purchase

100

187.71

Purchase

100

187.46

Purchase

100

187.51

Purchase

168

187.44

Purchase

100

187.57

Sale

1,188

187.04

Purchase

1,188

188.24

Purchase

43

187.58

Sale

115

187.96

Sale

400

187.79

Sale

200

187.67

Purchase

219

187.80

Purchase

450

187.88

Sale

5,668

188.24

Purchase

110

187.78

Purchase

112

188.25

Purchase

1,467

187.77

Sale

416

187.04

Purchase

416

188.24

Sale

68

187.58

Purchase

276

187.84

Sale

9

187.62

Purchase

34

187.75

Sale

34

187.79

Sale

11

187.70

Purchase

224

187.80

Purchase

20,037

188.24

Sale

10

187.54

Purchase

29

188.08

Sale

11

187.51

Purchase

9

188.11

Purchase

67

188.15

Sale

100

187.41

Sale

11

187.43

i) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

b) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None.

 


 

Is a Supplemental Form 8 attached? (Note 9) NO

Date of disclosure

28th April 2020

Contact name

Milos Naumovic

Telephone number

+44 203 650 8203

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection (Note 10)

 

 

 

Short Name: MILLENNIUM PARTNERS, L.P.
Category Code: RET
Sequence Number: 698334
Time of Receipt (offset from UTC): 20200428T124701+0100

Contacts

Millennium Partners, L.P.

Contacts

Millennium Partners, L.P.